 | • レポートコード：D0804-15752 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、120ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、糖尿病デバイス・薬物の世界市場を広く調査・分析し、今後の市場展望をまとめております。糖尿病デバイス・薬物の種類別市場規模（糖尿病デバイス、糖尿病薬）、用途別市場規模（診断・クリニック、ICU、在宅医療）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Medtronic、Companion Medical、Abbott Laboratories、BD、DexCom、Johnson & Johnson、Glenmark Pharmaceuticals、Bristol-Myers Squibb、Novo Nordisk、GlaxoSmithKline、Astrazeneca、Huadong Medicine、Novartis、Hisun Pharmacy、Takeda、MSD、Roche、Dongbao Pharmaceutical、North China Pharmaceutical Group Corporation、Sanofi、KELUN、Ginwa、Tianan Pharmaceutical ・地域別グローバル市場分析 2015年-2020年 ・糖尿病デバイス・薬物の北米市場（アメリカ、カナダ、メキシコ） ・糖尿病デバイス・薬物のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・糖尿病デバイス・薬物のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・糖尿病デバイス・薬物の南米市場（ブラジル、アルゼンチン） ・糖尿病デバイス・薬物の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：糖尿病デバイス、糖尿病薬 ・用途別分析：診断・クリニック、ICU、在宅医療 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Diabetes Devices and Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Diabetes Devices and Drugs sales will be xx in 2020 from Diabetes Devices and Drugs million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Diabetes Devices and Drugs market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Diabetes Devices and Drugs industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Diabetes Devices and Drugs and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Diabetes Devices and Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Diabetes Devices and Drugs market has been segmented into:
Diabetes Devices
Diabetes Drugs
By Application, Diabetes Devices and Drugs has been segmented into:
Diagnostic/Clinics
ICUs
Home Healthcare
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Diabetes Devices and Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Diabetes Devices and Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Diabetes Devices and Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Diabetes Devices and Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Diabetes Devices and Drugs Market Share Analysis
Diabetes Devices and Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Diabetes Devices and Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Diabetes Devices and Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Diabetes Devices and Drugs are:
Medtronic
Companion Medical
Abbott Laboratories
BD
DexCom
Johnson & Johnson
Glenmark Pharmaceuticals
Bristol-Myers Squibb
Novo Nordisk
GlaxoSmithKline
Astrazeneca
Huadong Medicine
Novartis
Hisun Pharmacy
Takeda
MSD
Roche
Dongbao Pharmaceutical
North China Pharmaceutical Group Corporation
Sanofi
KELUN
Ginwa
Tianan Pharmaceutical
Among other players domestic and global, Diabetes Devices and Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Diabetes Devices and Drugs Market Overview
1.1 Product Overview and Scope of Diabetes Devices and Drugs
1.2 Classification of Diabetes Devices and Drugs by Type
1.2.1 Global Diabetes Devices and Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Diabetes Devices and Drugs Revenue Market Share by Type in 2019
1.2.3 Diabetes Devices
1.2.4 Diabetes Drugs
1.3 Global Diabetes Devices and Drugs Market by Application
1.3.1 Overview: Global Diabetes Devices and Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Diagnostic/Clinics
1.3.3 ICUs
1.3.4 Home Healthcare
1.4 Global Diabetes Devices and Drugs Market by Regions
1.4.1 Global Diabetes Devices and Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Diabetes Devices and Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Diabetes Devices and Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Diabetes Devices and Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Diabetes Devices and Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Diabetes Devices and Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Diabetes Devices and Drugs Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Diabetes Devices and Drugs Industry Impact
1.5.1 COVID-19 Potential Implications for the Diabetes Devices and Drugs
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Diabetes Devices and Drugs
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Medtronic SWOT Analysis
2.1.4 Medtronic Product and Services
2.1.5 Medtronic Diabetes Devices and Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Companion Medical
2.2.1 Companion Medical Details
2.2.2 Companion Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Companion Medical SWOT Analysis
2.2.4 Companion Medical Product and Services
2.2.5 Companion Medical Diabetes Devices and Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Abbott Laboratories SWOT Analysis
2.3.4 Abbott Laboratories Product and Services
2.3.5 Abbott Laboratories Diabetes Devices and Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 BD
2.4.1 BD Details
2.4.2 BD Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 BD SWOT Analysis
2.4.4 BD Product and Services
2.4.5 BD Diabetes Devices and Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 DexCom
2.5.1 DexCom Details
2.5.2 DexCom Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 DexCom SWOT Analysis
2.5.4 DexCom Product and Services
2.5.5 DexCom Diabetes Devices and Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Johnson & Johnson Product and Services
2.6.4 Johnson & Johnson Diabetes Devices and Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Glenmark Pharmaceuticals
2.7.1 Glenmark Pharmaceuticals Details
2.7.2 Glenmark Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Glenmark Pharmaceuticals Product and Services
2.7.4 Glenmark Pharmaceuticals Diabetes Devices and Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bristol-Myers Squibb
2.8.1 Bristol-Myers Squibb Details
2.8.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bristol-Myers Squibb Product and Services
2.8.4 Bristol-Myers Squibb Diabetes Devices and Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.9 Novo Nordisk
2.9.1 Novo Nordisk Details
2.9.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Novo Nordisk Product and Services
2.9.4 Novo Nordisk Diabetes Devices and Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.10 GlaxoSmithKline
2.10.1 GlaxoSmithKline Details
2.10.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 GlaxoSmithKline Product and Services
2.10.4 GlaxoSmithKline Diabetes Devices and Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.11 Astrazeneca
2.11.1 Astrazeneca Details
2.11.2 Astrazeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Astrazeneca Product and Services
2.11.4 Astrazeneca Diabetes Devices and Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.12 Huadong Medicine
2.12.1 Huadong Medicine Details
2.12.2 Huadong Medicine Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Huadong Medicine Product and Services
2.12.4 Huadong Medicine Diabetes Devices and Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.13 Novartis
2.13.1 Novartis Details
2.13.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Novartis Product and Services
2.13.4 Novartis Diabetes Devices and Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.14 Hisun Pharmacy
2.14.1 Hisun Pharmacy Details
2.14.2 Hisun Pharmacy Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Hisun Pharmacy Product and Services
2.14.4 Hisun Pharmacy Diabetes Devices and Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.15 Takeda
2.15.1 Takeda Details
2.15.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Takeda Product and Services
2.15.4 Takeda Diabetes Devices and Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.16 MSD
2.16.1 MSD Details
2.16.2 MSD Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 MSD Product and Services
2.16.4 MSD Diabetes Devices and Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.17 Roche
2.17.1 Roche Details
2.17.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Roche Product and Services
2.17.4 Roche Diabetes Devices and Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.18 Dongbao Pharmaceutical
2.18.1 Dongbao Pharmaceutical Details
2.18.2 Dongbao Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Dongbao Pharmaceutical Product and Services
2.18.3 Dongbao Pharmaceutical Diabetes Devices and Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.19 North China Pharmaceutical Group Corporation
2.19.1 North China Pharmaceutical Group Corporation Details
2.19.2 North China Pharmaceutical Group Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 North China Pharmaceutical Group Corporation Product and Services
2.19.4 North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.20 Sanofi
2.20.1 Sanofi Details
2.20.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Sanofi Product and Services
2.20.4 Sanofi Diabetes Devices and Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.21 KELUN
2.21.1 KELUN Details
2.21.2 KELUN Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 KELUN Product and Services
2.21.4 KELUN Diabetes Devices and Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.22 Ginwa
2.22.1 Ginwa Details
2.22.2 Ginwa Major Business and Total Revenue (Financial Highlights) Analysis
2.22.3 Ginwa Product and Services
2.22.4 Ginwa Diabetes Devices and Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.23 Tianan Pharmaceutical
2.23.1 Tianan Pharmaceutical Details
2.23.2 Tianan Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.23.3 Tianan Pharmaceutical Product and Services
2.23.4 Tianan Pharmaceutical Diabetes Devices and Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Diabetes Devices and Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Diabetes Devices and Drugs Players Market Share
3.2.2 Top 10 Diabetes Devices and Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Diabetes Devices and Drugs Revenue and Market Share by Regions
4.2 North America Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
5 North America Diabetes Devices and Drugs Revenue by Countries
5.1 North America Diabetes Devices and Drugs Revenue by Countries (2015-2020)
5.2 USA Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
6 Europe Diabetes Devices and Drugs Revenue by Countries
6.1 Europe Diabetes Devices and Drugs Revenue by Countries (2015-2020)
6.2 Germany Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
6.4 France Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Diabetes Devices and Drugs Revenue by Countries
7.1 Asia-Pacific Diabetes Devices and Drugs Revenue by Countries (2015-2020)
7.2 China Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
7.5 India Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
8 South America Diabetes Devices and Drugs Revenue by Countries
8.1 South America Diabetes Devices and Drugs Revenue by Countries (2015-2020)
8.2 Brazil Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Diabetes Devices and Drugs by Countries
9.1 Middle East & Africa Diabetes Devices and Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Diabetes Devices and Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Diabetes Devices and Drugs Market Forecast by Type (2019-2024)
10.3 Diabetes Devices Revenue Growth Rate (2015-2025)
10.4 Diabetes Drugs Revenue Growth Rate (2015-2025)
11 Global Diabetes Devices and Drugs Market Segment by Application
11.1 Global Diabetes Devices and Drugs Revenue Market Share by Application (2015-2020)
11.2 Diabetes Devices and Drugs Market Forecast by Application (2019-2024)
11.3 Diagnostic/Clinics Revenue Growth (2015-2020)
11.4 ICUs Revenue Growth (2015-2020)
11.5 Home Healthcare Revenue Growth (2015-2020)
12 Global Diabetes Devices and Drugs Market Size Forecast (2021-2025)
12.1 Global Diabetes Devices and Drugs Market Size Forecast (2021-2025)
12.2 Global Diabetes Devices and Drugs Market Forecast by Regions (2021-2025)
12.3 North America Diabetes Devices and Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Diabetes Devices and Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Diabetes Devices and Drugs Revenue Market Forecast (2021-2025)
12.6 South America Diabetes Devices and Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Diabetes Devices and Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Diabetes Devices and Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Diabetes Devices and Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Diabetes Devices and Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Diabetes Devices and Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Diabetes Devices and Drugs Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Medtronic Corporate Information, Location and Competitors
Table 7. Medtronic Diabetes Devices and Drugs Major Business
Table 8. Medtronic Diabetes Devices and Drugs Total Revenue (USD Million) (2017-2018)
Table 9. Medtronic SWOT Analysis
Table 10. Medtronic Diabetes Devices and Drugs Product and Solutions
Table 11. Medtronic Diabetes Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Companion Medical Corporate Information, Location and Competitors
Table 13. Companion Medical Diabetes Devices and Drugs Major Business
Table 14. Companion Medical Diabetes Devices and Drugs Total Revenue (USD Million) (2018-2019)
Table 15. Companion Medical SWOT Analysis
Table 16. Companion Medical Diabetes Devices and Drugs Product and Solutions
Table 17. Companion Medical Diabetes Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Abbott Laboratories Corporate Information, Location and Competitors
Table 19. Abbott Laboratories Diabetes Devices and Drugs Major Business
Table 20. Abbott Laboratories Diabetes Devices and Drugs Total Revenue (USD Million) (2017-2018)
Table 21. Abbott Laboratories SWOT Analysis
Table 22. Abbott Laboratories Diabetes Devices and Drugs Product and Solutions
Table 23. Abbott Laboratories Diabetes Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. BD Corporate Information, Location and Competitors
Table 25. BD Diabetes Devices and Drugs Major Business
Table 26. BD Diabetes Devices and Drugs Total Revenue (USD Million) (2017-2018)
Table 27. BD SWOT Analysis
Table 28. BD Diabetes Devices and Drugs Product and Solutions
Table 29. BD Diabetes Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. DexCom Corporate Information, Location and Competitors
Table 31. DexCom Diabetes Devices and Drugs Major Business
Table 32. DexCom Diabetes Devices and Drugs Total Revenue (USD Million) (2017-2018)
Table 33. DexCom SWOT Analysis
Table 34. DexCom Diabetes Devices and Drugs Product and Solutions
Table 35. DexCom Diabetes Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Johnson & Johnson Corporate Information, Location and Competitors
Table 37. Johnson & Johnson Diabetes Devices and Drugs Major Business
Table 38. Johnson & Johnson Diabetes Devices and Drugs Total Revenue (USD Million) (2017-2018)
Table 39. Johnson & Johnson SWOT Analysis
Table 40. Johnson & Johnson Diabetes Devices and Drugs Product and Solutions
Table 41. Johnson & Johnson Diabetes Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Glenmark Pharmaceuticals Corporate Information, Location and Competitors
Table 43. Glenmark Pharmaceuticals Diabetes Devices and Drugs Major Business
Table 44. Glenmark Pharmaceuticals Diabetes Devices and Drugs Total Revenue (USD Million) (2017-2018)
Table 45. Glenmark Pharmaceuticals SWOT Analysis
Table 46. Glenmark Pharmaceuticals Diabetes Devices and Drugs Product and Solutions
Table 47. Glenmark Pharmaceuticals Diabetes Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 49. Bristol-Myers Squibb Diabetes Devices and Drugs Major Business
Table 50. Bristol-Myers Squibb Diabetes Devices and Drugs Total Revenue (USD Million) (2017-2018)
Table 51. Bristol-Myers Squibb SWOT Analysis
Table 52. Bristol-Myers Squibb Diabetes Devices and Drugs Product and Solutions
Table 53. Bristol-Myers Squibb Diabetes Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Novo Nordisk Corporate Information, Location and Competitors
Table 55. Novo Nordisk Diabetes Devices and Drugs Major Business
Table 56. Novo Nordisk Diabetes Devices and Drugs Total Revenue (USD Million) (2017-2018)
Table 57. Novo Nordisk SWOT Analysis
Table 58. Novo Nordisk Diabetes Devices and Drugs Product and Solutions
Table 59. Novo Nordisk Diabetes Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. GlaxoSmithKline Corporate Information, Location and Competitors
Table 61. GlaxoSmithKline Diabetes Devices and Drugs Major Business
Table 62. GlaxoSmithKline Diabetes Devices and Drugs Total Revenue (USD Million) (2017-2018)
Table 63. GlaxoSmithKline SWOT Analysis
Table 64. GlaxoSmithKline Diabetes Devices and Drugs Product and Solutions
Table 65. GlaxoSmithKline Diabetes Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Astrazeneca Corporate Information, Location and Competitors
Table 67. Astrazeneca Diabetes Devices and Drugs Major Business
Table 68. Astrazeneca Diabetes Devices and Drugs Total Revenue (USD Million) (2017-2018)
Table 69. Astrazeneca SWOT Analysis
Table 70. Astrazeneca Diabetes Devices and Drugs Product and Solutions
Table 71. Astrazeneca Diabetes Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Huadong Medicine Corporate Information, Location and Competitors
Table 73. Huadong Medicine Diabetes Devices and Drugs Major Business
Table 74. Huadong Medicine Diabetes Devices and Drugs Total Revenue (USD Million) (2017-2018)
Table 75. Huadong Medicine SWOT Analysis
Table 76. Huadong Medicine Diabetes Devices and Drugs Product and Solutions
Table 77. Huadong Medicine Diabetes Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Novartis Corporate Information, Location and Competitors
Table 79. Novartis Diabetes Devices and Drugs Major Business
Table 80. Novartis Diabetes Devices and Drugs Total Revenue (USD Million) (2017-2018)
Table 81. Novartis SWOT Analysis
Table 82. Novartis Diabetes Devices and Drugs Product and Solutions
Table 83. Novartis Diabetes Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Hisun Pharmacy Corporate Information, Location and Competitors
Table 85. Hisun Pharmacy Diabetes Devices and Drugs Major Business
Table 86. Hisun Pharmacy Diabetes Devices and Drugs Total Revenue (USD Million) (2017-2018)
Table 87. Hisun Pharmacy SWOT Analysis
Table 88. Hisun Pharmacy Diabetes Devices and Drugs Product and Solutions
Table 89. Hisun Pharmacy Diabetes Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Takeda Corporate Information, Location and Competitors
Table 91. Takeda Diabetes Devices and Drugs Major Business
Table 92. Takeda Diabetes Devices and Drugs Total Revenue (USD Million) (2017-2018)
Table 93. Takeda SWOT Analysis
Table 94. Takeda Diabetes Devices and Drugs Product and Solutions
Table 95. Takeda Diabetes Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. MSD Corporate Information, Location and Competitors
Table 97. MSD Diabetes Devices and Drugs Major Business
Table 98. MSD Diabetes Devices and Drugs Total Revenue (USD Million) (2017-2018)
Table 99. MSD SWOT Analysis
Table 100. MSD Diabetes Devices and Drugs Product and Solutions
Table 101. MSD Diabetes Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Roche Corporate Information, Location and Competitors
Table 103. Roche Diabetes Devices and Drugs Major Business
Table 104. Roche Diabetes Devices and Drugs Total Revenue (USD Million) (2017-2018)
Table 105. Roche SWOT Analysis
Table 106. Roche Diabetes Devices and Drugs Product and Solutions
Table 107. Roche Diabetes Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Dongbao Pharmaceutical Diabetes Devices and Drugs Type and Application
Table 109. Dongbao Pharmaceutical Diabetes Devices and Drugs Major Business
Table 110. Dongbao Pharmaceutical Diabetes Devices and Drugs Total Revenue (USD Million) (2017-2018)
Table 111. Dongbao Pharmaceutical SWOT Analysis
Table 112. Dongbao Pharmaceutical Diabetes Devices and Drugs Product and Solutions
Table 113. Dongbao Pharmaceutical Diabetes Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. North China Pharmaceutical Group Corporation Corporate Information, Location and Competitors
Table 115. North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Major Business
Table 116. North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Total Revenue (USD Million) (2017-2018)
Table 117. North China Pharmaceutical Group Corporation SWOT Analysis
Table 118. North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Product and Solutions
Table 119. North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 120. Sanofi Corporate Information, Location and Competitors
Table 121. Sanofi Diabetes Devices and Drugs Major Business
Table 122. Sanofi Diabetes Devices and Drugs Total Revenue (USD Million) (2017-2018)
Table 123. Sanofi SWOT Analysis
Table 124. Sanofi Diabetes Devices and Drugs Product and Solutions
Table 125. Sanofi Diabetes Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 126. KELUN Corporate Information, Location and Competitors
Table 127. KELUN Diabetes Devices and Drugs Major Business
Table 128. KELUN Diabetes Devices and Drugs Total Revenue (USD Million) (2017-2018)
Table 129. KELUN SWOT Analysis
Table 130. KELUN Diabetes Devices and Drugs Product and Solutions
Table 131. KELUN Diabetes Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 132. Ginwa Corporate Information, Location and Competitors
Table 133. Ginwa Diabetes Devices and Drugs Major Business
Table 134. Ginwa Diabetes Devices and Drugs Total Revenue (USD Million) (2017-2018)
Table 135. Ginwa SWOT Analysis
Table 136. Ginwa Diabetes Devices and Drugs Product and Solutions
Table 137. Ginwa Diabetes Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 138. Tianan Pharmaceutical Corporate Information, Location and Competitors
Table 139. Tianan Pharmaceutical Diabetes Devices and Drugs Major Business
Table 140. Tianan Pharmaceutical Diabetes Devices and Drugs Total Revenue (USD Million) (2017-2018)
Table 141. Tianan Pharmaceutical SWOT Analysis
Table 142. Tianan Pharmaceutical Diabetes Devices and Drugs Product and Solutions
Table 143. Tianan Pharmaceutical Diabetes Devices and Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 144. Global Diabetes Devices and Drugs Revenue (Million USD) by Players (2015-2020)
Table 145. Global Diabetes Devices and Drugs Revenue Share by Players (2015-2020)
Table 146. Global Diabetes Devices and Drugs Revenue (Million USD) by Regions (2015-2020)
Table 147. Global Diabetes Devices and Drugs Revenue Market Share by Regions (2015-2020)
Table 148. North America Diabetes Devices and Drugs Revenue by Countries (2015-2020)
Table 149. North America Diabetes Devices and Drugs Revenue Market Share by Countries (2015-2020)
Table 150. Europe Diabetes Devices and Drugs Revenue (Million USD) by Countries (2015-2020)
Table 151. Asia-Pacific Diabetes Devices and Drugs Revenue (Million USD) by Countries (2015-2020)
Table 152. South America Diabetes Devices and Drugs Revenue by Countries (2015-2020)
Table 153. South America Diabetes Devices and Drugs Revenue Market Share by Countries (2015-2020)
Table 154. Middle East and Africa Diabetes Devices and Drugs Revenue (Million USD) by Countries (2015-2020)
Table 155. Middle East and Africa Diabetes Devices and Drugs Revenue Market Share by Countries (2015-2020)
Table 156. Global Diabetes Devices and Drugs Revenue (Million USD) by Type (2015-2020)
Table 157. Global Diabetes Devices and Drugs Revenue Share by Type (2015-2020)
Table 158. Global Diabetes Devices and Drugs Revenue Forecast by Type (2021-2025)
Table 159. Global Diabetes Devices and Drugs Revenue by Application (2015-2020)
Table 160. Global Diabetes Devices and Drugs Revenue Share by Application (2015-2020)
Table 161. Global Diabetes Devices and Drugs Revenue Forecast by Application (2021-2025)
Table 162. Global Diabetes Devices and Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Diabetes Devices and Drugs Picture
Figure 2. Global Diabetes Devices and Drugs Revenue Market Share by Type in 2019
Figure 3. Diabetes Devices Picture
Figure 4. Diabetes Drugs Picture
Figure 5. Diabetes Devices and Drugs Revenue Market Share by Application in 2019
Figure 6. Diagnostic/Clinics Picture
Figure 7. ICUs Picture
Figure 8. Home Healthcare Picture
Figure 9. Global Diabetes Devices and Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Diabetes Devices and Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Diabetes Devices and Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Diabetes Devices and Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Diabetes Devices and Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Diabetes Devices and Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Diabetes Devices and Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Diabetes Devices and Drugs Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Diabetes Devices and Drugs Revenue Market Share in 2019
Figure 18. Global Top 10 Players Diabetes Devices and Drugs Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Diabetes Devices and Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Diabetes Devices and Drugs Revenue Market Share by Regions (2015-2020)
Figure 22. Global Diabetes Devices and Drugs Revenue Market Share by Regions in 2018
Figure 23. North America Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
Figure 24. Europe Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
Figure 26. South America Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
Figure 28. North America Diabetes Devices and Drugs Revenue Market Share by Countries (2015-2020)
Figure 29. North America Diabetes Devices and Drugs Revenue Market Share by Countries in 2019
Figure 30. USA Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
Figure 31. Canada Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
Figure 33. Europe Diabetes Devices and Drugs Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Diabetes Devices and Drugs Revenue Market Share by Countries in 2019
Figure 35. Germany Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
Figure 36. UK Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
Figure 37. France Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
Figure 38. Russia Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
Figure 39. Italy Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Diabetes Devices and Drugs Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Diabetes Devices and Drugs Revenue Market Share by Countries in 2019
Figure 42. China Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
Figure 43. Japan Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
Figure 44. Korea Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
Figure 45. India Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
Figure 47. South America Diabetes Devices and Drugs Revenue Market Share by Countries (2015-2020)
Figure 48. South America Diabetes Devices and Drugs Revenue Market Share by Countries in 2019
Figure 49. Brazil Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Diabetes Devices and Drugs Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Diabetes Devices and Drugs Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
Figure 54. UAE Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Diabetes Devices and Drugs Revenue and Growth Rate (2015-2020)
Figure 57. Global Diabetes Devices and Drugs Revenue Share by Type (2015-2020)
Figure 58. Global Diabetes Devices and Drugs Revenue Share by Type in 2019
Figure 59. Global Diabetes Devices and Drugs Market Share Forecast by Type (2021-2025)
Figure 60. Global Diabetes Devices Revenue Growth Rate (2015-2020)
Figure 61. Global Diabetes Drugs Revenue Growth Rate (2015-2020)
Figure 62. Global Diabetes Devices and Drugs Revenue Share by Application (2015-2020)
Figure 63. Global Diabetes Devices and Drugs Revenue Share by Application in 2019
Figure 64. Global Diabetes Devices and Drugs Market Share Forecast by Application (2021-2025)
Figure 65. Global Diagnostic/Clinics Revenue Growth Rate (2015-2020)
Figure 66. Global ICUs Revenue Growth Rate (2015-2020)
Figure 67. Global Home Healthcare Revenue Growth Rate (2015-2020)
Figure 68. Global Diabetes Devices and Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Diabetes Devices and Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Diabetes Devices and Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Diabetes Devices and Drugs Revenue Market Forecast (2021-2025)
Figure 72. Europe Diabetes Devices and Drugs Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Diabetes Devices and Drugs Revenue Market Forecast (2021-2025)
Figure 74. South America Diabetes Devices and Drugs Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Diabetes Devices and Drugs Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
ミリ波糖尿病治療装置の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Millimeter Wave Diabetes Treatment Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Mi…- ペット用糖尿病ケア機器の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Pet Diabetes Care Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 糖尿病採血器具の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Diabetes Blood Collection Equipment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Diabetes …
- ウェアラブル治療装置の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Wearable Therapeutic Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Wearable Therape…
- 人工膵臓デバイスシステムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Artificial Pancreas Devices Systems market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…